US Patent Issued to Evidium on May 13 for "Determining a next-best action across medical conditions" (American, British Inventors)

ALEXANDRIA, Va., June 12 -- United States Patent no. 12,300,392, issued on May 13, was assigned to Evidium Inc. (San Francisco).

"Determining a next-best action across medical conditions" was invented by Carl Bate (San Francisco), Wian Stipp (Somerleyton, Great Britain), Thomas Unger (Tiburon, Calif.), David A. Epstein (Croton-on-Hudson, N.Y.), Matthew McSorley (Pittsburgh), Fady Nakhla (San Francisco), David Robinson (Santa Cruz, Calif.), Jennifer May Lee (London) and Arthur Book (San Francisco).

According to the abstract* released by the U.S. Patent & Trademark Office: "A computational evidence platform extracts clinical concepts from medical evidence sources and creates a database of elemental diagnostic factors and elemental investiga...